These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Randomized, double-blinded, placebo-controlled, trial of risedronate for the prevention of bone mineral density loss in nonmetastatic prostate cancer patients receiving radiation therapy plus androgen deprivation therapy. Choo R; Lukka H; Cheung P; Corbett T; Briones-Urbina R; Vieth R; Ehrlich L; Kiss A; Danjoux C Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1239-45. PubMed ID: 23265571 [TBL] [Abstract][Full Text] [Related]
14. Monthly dosing with risedronate 50 mg on three consecutive days a month compared with daily dosing with risedronate 5 mg: a 6-month pilot study. Racewicz AJ; Schofield PJ; Cahall DL; Cline GA; Burgio DE Curr Med Res Opin; 2007 Dec; 23(12):3079-89. PubMed ID: 17971285 [TBL] [Abstract][Full Text] [Related]
15. Evidence for safety and efficacy of risedronate in men with osteoporosis over 4 years of treatment: Results from the 2-year, open-label, extension study of a 2-year, randomized, double-blind, placebo-controlled study. Boonen S; Lorenc RS; Wenderoth D; Stoner KJ; Eusebio R; Orwoll ES Bone; 2012 Sep; 51(3):383-8. PubMed ID: 22750403 [TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of risedronate in patients with age-related reduced renal function as estimated by the Cockcroft and Gault method: a pooled analysis of nine clinical trials. Miller PD; Roux C; Boonen S; Barton IP; Dunlap LE; Burgio DE J Bone Miner Res; 2005 Dec; 20(12):2105-15. PubMed ID: 16294264 [TBL] [Abstract][Full Text] [Related]
17. Effect of risedronate on osteocyte viability and bone turnover in paired iliac bone biopsies from early postmenopausal women. Qiu S; Phipps RJ; Ebetino FH; Palnitkar S; Sudhaker Rao D Calcif Tissue Int; 2010 Nov; 87(5):392-7. PubMed ID: 20809096 [TBL] [Abstract][Full Text] [Related]
18. Once-weekly risedronate in men with osteoporosis: results of a 2-year, placebo-controlled, double-blind, multicenter study. Boonen S; Orwoll ES; Wenderoth D; Stoner KJ; Eusebio R; Delmas PD J Bone Miner Res; 2009 Apr; 24(4):719-25. PubMed ID: 19049326 [TBL] [Abstract][Full Text] [Related]
19. Profound refractory hypocalcemia after thyroidectomy in a patient receiving chronic oral bisphosphonate therapy. Richmond BK Am Surg; 2005 Oct; 71(10):872-3. PubMed ID: 16468539 [TBL] [Abstract][Full Text] [Related]
20. [Osteoporosis management in general practice. Preventing spontaneous bone fractures]. MMW Fortschr Med; 2010 Jul; 152(25-27):54-5. PubMed ID: 20672666 [No Abstract] [Full Text] [Related] [Next] [New Search]